Thrivent Financial for Lutherans Cuts Stake in DENTSPLY SIRONA Inc. $XRAY

Thrivent Financial for Lutherans lessened its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 41.3% in the 3rd quarter, Holdings Channel reports. The firm owned 104,694 shares of the medical instruments supplier’s stock after selling 73,793 shares during the period. Thrivent Financial for Lutherans’ holdings in DENTSPLY SIRONA were worth $1,328,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of XRAY. AQR Capital Management LLC increased its stake in DENTSPLY SIRONA by 109.8% during the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after buying an additional 6,970,086 shares in the last quarter. Norges Bank acquired a new stake in shares of DENTSPLY SIRONA in the second quarter worth approximately $39,700,000. Goldman Sachs Group Inc. increased its position in shares of DENTSPLY SIRONA by 827.3% during the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock worth $36,378,000 after purchasing an additional 2,172,343 shares in the last quarter. Lazard Asset Management LLC raised its stake in DENTSPLY SIRONA by 8.0% in the 2nd quarter. Lazard Asset Management LLC now owns 10,107,657 shares of the medical instruments supplier’s stock valued at $160,508,000 after purchasing an additional 745,421 shares during the last quarter. Finally, Prudential Financial Inc. lifted its holdings in DENTSPLY SIRONA by 67.9% in the 2nd quarter. Prudential Financial Inc. now owns 1,158,415 shares of the medical instruments supplier’s stock valued at $18,396,000 after purchasing an additional 468,415 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on XRAY. Mizuho upped their target price on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a report on Tuesday, January 20th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, January 21st. Wells Fargo & Company lowered their target price on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a report on Friday, November 7th. JPMorgan Chase & Co. cut their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Friday, November 7th. Finally, Wall Street Zen downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Two research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $14.25.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $12.95 on Friday. The firm has a 50 day simple moving average of $12.11 and a 200-day simple moving average of $12.57. The stock has a market cap of $2.58 billion, a price-to-earnings ratio of -2.93, a price-to-earnings-growth ratio of 1.01 and a beta of 1.01. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. DENTSPLY SIRONA Inc. has a 1-year low of $9.85 and a 1-year high of $19.27.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 9th. Shareholders of record on Friday, December 26th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 annualized dividend and a yield of 4.9%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.48%.

Insider Buying and Selling

In other news, Director Gregory T. Lucier sold 82,200 shares of the company’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.50% of the stock is owned by corporate insiders.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.